Augmedix (NASDAQ:AUGX) Rating Lowered to Hold at Maxim Group

Maxim Group lowered shares of Augmedix (NASDAQ:AUGX – Free Report) from a buy rating to a hold rating in a report issued on Tuesday, Marketbeat Ratings reports. The brokerage currently has $5.00 target price on the stock. A number of other equities analysts also recently commented on AUGX. B. Riley started coverage on shares of […]

Related Keywords

United States ,Mian Shakil ,Securities Exchange Commission ,Jump Financial ,Maxim Group ,Augmedix Inc ,Acadian Asset Management ,Essex Investment Management Co ,Barclays Plc ,Worth Venture Partners ,Free Report ,Marketbeat Ratings ,Get Free Report ,Exchange Commission ,Investment Management ,Asset Management ,Augmedix Live ,Augmedix Go Assist ,Augmedix Prep ,Augmedix Daily ,